NO20072853L - Diagnose og prognose av infeksjonssykdommers kliniske fenotype og andre fysiologiske tilstander ved anvendelse av genekspresjon av biomarkorer i vertens blod - Google Patents
Diagnose og prognose av infeksjonssykdommers kliniske fenotype og andre fysiologiske tilstander ved anvendelse av genekspresjon av biomarkorer i vertens blodInfo
- Publication number
- NO20072853L NO20072853L NO20072853A NO20072853A NO20072853L NO 20072853 L NO20072853 L NO 20072853L NO 20072853 A NO20072853 A NO 20072853A NO 20072853 A NO20072853 A NO 20072853A NO 20072853 L NO20072853 L NO 20072853L
- Authority
- NO
- Norway
- Prior art keywords
- host
- gene expression
- prognosis
- diagnosis
- infectious disease
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 9
- 230000014509 gene expression Effects 0.000 title abstract 3
- 208000035473 Communicable disease Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000004962 physiological condition Effects 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
- 230000002458 infectious effect Effects 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 244000052769 pathogen Species 0.000 abstract 4
- 230000001717 pathogenic effect Effects 0.000 abstract 4
- 206010061818 Disease progression Diseases 0.000 abstract 1
- 230000005750 disease progression Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62650004P | 2004-11-05 | 2004-11-05 | |
| PCT/US2005/040196 WO2007011412A2 (en) | 2004-11-05 | 2005-11-07 | Diagnosis and prognosis of infectious diesease clinical phenotypes and other physiologic states using host gene expresion biomarkers in blood |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072853L true NO20072853L (no) | 2007-08-06 |
Family
ID=37669288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072853A NO20072853L (no) | 2004-11-05 | 2007-06-05 | Diagnose og prognose av infeksjonssykdommers kliniske fenotype og andre fysiologiske tilstander ved anvendelse av genekspresjon av biomarkorer i vertens blod |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20080020379A1 (de) |
| EP (1) | EP1807540A4 (de) |
| JP (1) | JP2008518626A (de) |
| KR (1) | KR20070085817A (de) |
| CN (1) | CN101218355A (de) |
| AU (1) | AU2005334466B2 (de) |
| CA (1) | CA2586374A1 (de) |
| NO (1) | NO20072853L (de) |
| NZ (1) | NZ555575A (de) |
| WO (1) | WO2007011412A2 (de) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2661168T3 (es) | 2003-07-12 | 2018-03-27 | Accelerate Diagnostics, Inc. | Biodetección sensible y rápida |
| US20120077206A1 (en) | 2003-07-12 | 2012-03-29 | Accelr8 Technology Corporation | Rapid Microbial Detection and Antimicrobial Susceptibility Testing |
| US8143600B2 (en) * | 2008-02-18 | 2012-03-27 | Visiongate, Inc. | 3D imaging of live cells with ultraviolet radiation |
| EP2347352B1 (de) * | 2008-09-16 | 2019-11-06 | Beckman Coulter, Inc. | Interaktiver baum-plot für durchflusscytometriedaten |
| EP2430579A2 (de) * | 2009-05-11 | 2012-03-21 | Koninklijke Philips Electronics N.V. | Einrichtung und verfahren zum vergleichen molekularer signaturen |
| EP3859746B1 (de) | 2009-10-19 | 2024-10-16 | Labrador Diagnostics LLC | Integriertes system zur erfassung und analyse von gesundheitsdaten |
| WO2011082392A1 (en) * | 2010-01-04 | 2011-07-07 | Lineagen, Inc. | Gene biomarkers of lung function |
| US9709565B2 (en) | 2010-04-21 | 2017-07-18 | Memed Diagnostics Ltd. | Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof |
| US9165051B2 (en) * | 2010-08-24 | 2015-10-20 | Board Of Trustees Of The University Of Illinois | Systems and methods for detecting a novel data class |
| US20140032125A1 (en) * | 2011-02-12 | 2014-01-30 | Siemens Healthcare Diagnostics Inc. | Environment and Method for Rapid Analysis of Genomic Sequence Data |
| US10254204B2 (en) | 2011-03-07 | 2019-04-09 | Accelerate Diagnostics, Inc. | Membrane-assisted purification |
| US9434937B2 (en) | 2011-03-07 | 2016-09-06 | Accelerate Diagnostics, Inc. | Rapid cell purification systems |
| DE102011005235B4 (de) * | 2011-03-08 | 2017-05-24 | Sirs-Lab Gmbh | Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten |
| CN108802385B (zh) | 2012-02-09 | 2022-02-08 | 米密德诊断学有限公司 | 用于诊断感染的标记和决定因素和其使用方法 |
| EP2914740B1 (de) * | 2012-10-30 | 2017-09-13 | Imperial Innovations Ltd | Verfahren zur detektion aktiver tuberculosis in kindern in der anwesenheit einer komorbiditàt |
| TWI509074B (zh) * | 2012-11-28 | 2015-11-21 | Fooyin University Hospital | Enzyme Gene Chip Detection Reagent and Its Detection |
| US20140278135A1 (en) * | 2013-03-15 | 2014-09-18 | Myriad Genetics, Inc. | Electronic variant classification |
| US9677109B2 (en) | 2013-03-15 | 2017-06-13 | Accelerate Diagnostics, Inc. | Rapid determination of microbial growth and antimicrobial susceptibility |
| WO2015048098A1 (en) | 2013-09-24 | 2015-04-02 | Washington University | Diagnostic methods for infectious disease using endogenous gene expression |
| CN106415563B (zh) * | 2013-12-16 | 2020-06-05 | 菲利普莫里斯生产公司 | 用于预测个体的吸烟状况的系统和方法 |
| BR112017002884A2 (pt) | 2014-08-14 | 2018-01-30 | Memed Diagnostics Ltd | ?análise computacional de dados biológicos por meio do uso de variedade e hiperplano? |
| WO2016026258A1 (en) * | 2014-08-22 | 2016-02-25 | Institute Of Biophysics, Chinese Academy Of Sciences | Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the ifp35 family of proteins |
| US20170234873A1 (en) | 2014-10-14 | 2017-08-17 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
| CN107209184B (zh) | 2014-12-11 | 2020-04-24 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| US10023895B2 (en) | 2015-03-30 | 2018-07-17 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing |
| US10253355B2 (en) | 2015-03-30 | 2019-04-09 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
| JP6706627B2 (ja) * | 2015-04-08 | 2020-06-10 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 集中治療室における臨床値の自動化された分析及びリスク通知のためのシステム |
| US10741278B2 (en) * | 2015-04-20 | 2020-08-11 | Cardeya Corporation | Pathogen detection and display system |
| WO2016208776A1 (ja) | 2015-06-25 | 2016-12-29 | 株式会社国際電気通信基礎技術研究所 | 多器官連関システムを基盤とした予測装置、及び予測プログラム |
| US10073890B1 (en) | 2015-08-03 | 2018-09-11 | Marca Research & Development International, Llc | Systems and methods for patent reference comparison in a combined semantical-probabilistic algorithm |
| US10621499B1 (en) | 2015-08-03 | 2020-04-14 | Marca Research & Development International, Llc | Systems and methods for semantic understanding of digital information |
| DK3356558T3 (da) * | 2015-09-30 | 2022-04-25 | Immunexpress Pty Ltd | Sirs patogenbiomarkører og anvendelser deraf |
| IL294121B2 (en) | 2016-03-03 | 2023-09-01 | Memed Diagnostics Ltd | An RNA test to diagnose the type of infection |
| EP3423590A4 (de) | 2016-03-03 | 2020-02-26 | Memed Diagnostics Ltd. | Rna-determinanten zur unterscheidung zwischen bakteriellen und viralen infektionen |
| EP3433017A4 (de) * | 2016-03-25 | 2020-01-01 | Bioceryx Inc. | Vorrichtungen und verfahren zur beurteilung von zielsequenzenzahlen |
| EP3466446B1 (de) | 2016-03-29 | 2023-12-27 | Karydo Therapeutix, Inc. | Pharmazeutische zusammensetzung oder nahrungsmittelzusammensetzung und verfahren zur beurteilung der wirkung eines wirkstoffs in vivo |
| JP6432962B2 (ja) | 2016-03-29 | 2018-12-05 | 株式会社国際電気通信基礎技術研究所 | 腎機能低下、慢性腎疾患及び腎不全からなる群から選択される少なくとも一種の疾患を予防、又は治療するための有効成分の候補物質のスクリーニング方法 |
| US10540439B2 (en) | 2016-04-15 | 2020-01-21 | Marca Research & Development International, Llc | Systems and methods for identifying evidentiary information |
| WO2018011796A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Early diagnosis of infections |
| CA3027341A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| WO2018060999A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification |
| US11385241B2 (en) | 2016-09-29 | 2022-07-12 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US10209260B2 (en) | 2017-07-05 | 2019-02-19 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| WO2019193878A1 (ja) * | 2018-04-06 | 2019-10-10 | パナソニックＩｐマネジメント株式会社 | 病原体検出装置および病原体検出方法 |
| WO2020102786A1 (en) * | 2018-11-16 | 2020-05-22 | Texas Biomedical Research Institute | Methods for evaluation of duration of mycobacterial infection |
| KR20220054401A (ko) * | 2019-09-03 | 2022-05-02 | 더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 | 감염의 숙주 rna 바이오마커의 신속한 조기-검출 및 인간의 covid-19 코로나바이러스 감염의 조기 식별을 위한 시스템, 방법 및 조성물 |
| EP4446439A3 (de) * | 2019-11-13 | 2025-03-26 | The Regents Of The University Of Colorado, A Body Corporate | Identifizierung von wirts-rna-biomarkern einer infektion |
| CA3173021A1 (en) * | 2020-03-26 | 2021-09-30 | Chris Wheeler | Methods and apparatuses for early diagnosis of lung infection acuity |
| CN112001329B (zh) * | 2020-08-26 | 2021-11-30 | 深圳太力生物技术有限责任公司 | 蛋白表达量的预测方法、装置、计算机设备和存储介质 |
| KR20220078117A (ko) | 2020-12-03 | 2022-06-10 | 원광대학교산학협력단 | 혈액샘플을 이용한 코로나 환자 사망률 예측 시스템 및 방법 |
| CN114717339B (zh) * | 2021-01-05 | 2024-04-05 | 深圳华大生命科学研究院 | 检测snp位点的试剂在制备试剂盒中的用途 |
| CN113265452A (zh) * | 2021-05-14 | 2021-08-17 | 北京大学人民医院 | 一种基于Nanopore宏基因组RNA-seq的生物信息学检测病原体的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5512439A (en) * | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
| US5701256A (en) * | 1995-05-31 | 1997-12-23 | Cold Spring Harbor Laboratory | Method and apparatus for biological sequence comparison |
| US5830679A (en) * | 1996-03-01 | 1998-11-03 | New England Medical Center Hospitals, Inc. | Diagnostic blood test to identify infants at risk for sepsis |
| US6519583B1 (en) * | 1997-05-15 | 2003-02-11 | Incyte Pharmaceuticals, Inc. | Graphical viewer for biomolecular sequence data |
| WO2000046404A1 (en) * | 1999-02-05 | 2000-08-10 | Wrair Walter Reed Army Institute Of Research | Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| AU6947700A (en) * | 1999-09-01 | 2001-03-26 | Monsanto Technology Llc | Plant regulatory sequences for selective control of gene expression |
| AU2002255478A1 (en) * | 2001-01-10 | 2002-09-12 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
| US6905827B2 (en) * | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| US20040038201A1 (en) * | 2002-01-22 | 2004-02-26 | Whitehead Institute For Biomedical Research | Diagnostic and therapeutic applications for biomarkers of infection |
| US20050003369A1 (en) * | 2002-10-10 | 2005-01-06 | Affymetrix, Inc. | Method for depleting specific nucleic acids from a mixture |
| CA2505843A1 (en) * | 2002-11-12 | 2004-05-27 | Becton, Dickinson And Company | Diagnosis of sepsis or sirs using biomarker profiles |
| WO2005003370A2 (en) * | 2003-06-06 | 2005-01-13 | Gene Logic, Inc. | Methods for enhancing gene expression analysis |
-
2005
- 2005-11-07 CN CNA2005800458396A patent/CN101218355A/zh active Pending
- 2005-11-07 AU AU2005334466A patent/AU2005334466B2/en not_active Ceased
- 2005-11-07 WO PCT/US2005/040196 patent/WO2007011412A2/en not_active Ceased
- 2005-11-07 CA CA002586374A patent/CA2586374A1/en not_active Abandoned
- 2005-11-07 KR KR1020077012752A patent/KR20070085817A/ko not_active Ceased
- 2005-11-07 NZ NZ555575A patent/NZ555575A/en not_active IP Right Cessation
- 2005-11-07 JP JP2007540113A patent/JP2008518626A/ja active Pending
- 2005-11-07 US US11/268,373 patent/US20080020379A1/en not_active Abandoned
- 2005-11-07 EP EP05858476A patent/EP1807540A4/de not_active Withdrawn
-
2007
- 2007-06-05 NO NO20072853A patent/NO20072853L/no not_active Application Discontinuation
-
2010
- 2010-02-26 US US12/713,554 patent/US20110183856A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1807540A4 (de) | 2008-12-10 |
| WO2007011412A9 (en) | 2007-07-26 |
| AU2005334466A1 (en) | 2007-01-25 |
| JP2008518626A (ja) | 2008-06-05 |
| WO2007011412A2 (en) | 2007-01-25 |
| KR20070085817A (ko) | 2007-08-27 |
| WO2007011412A3 (en) | 2007-10-11 |
| US20110183856A1 (en) | 2011-07-28 |
| NZ555575A (en) | 2010-11-26 |
| CN101218355A (zh) | 2008-07-09 |
| CA2586374A1 (en) | 2007-01-25 |
| AU2005334466B2 (en) | 2011-05-26 |
| EP1807540A2 (de) | 2007-07-18 |
| US20080020379A1 (en) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072853L (no) | Diagnose og prognose av infeksjonssykdommers kliniske fenotype og andre fysiologiske tilstander ved anvendelse av genekspresjon av biomarkorer i vertens blod | |
| Keita et al. | Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks | |
| Ansart et al. | Illnesses in travelers returning from the tropics: a prospective study of 622 patients | |
| Stoler et al. | The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials | |
| NO20030251L (no) | Fremgangsmåte for differensiering mellom biologiske tilstander basert på skjulte mönstre fra biologiske data | |
| DK1439897T3 (da) | Fremgangsmåder til adskillelse af sjældne celler fra væskeprøver | |
| EP1810026A4 (de) | B7-h1 und verfahren zur diagnose, prognose und behandlung von krebs | |
| WO2006084196A3 (en) | Method for defining virtual patient populations | |
| Wang et al. | Cost-effectiveness of secondary screening modalities for hypertension | |
| Islam et al. | Comparative Analysis of Serum Creatinine and Albuminuria as Biomarkers for Diabetic Nephropathy in Young Patients with Type 2 Diabetes | |
| Chee et al. | Comparison of prevalence of dengue maculopathy during two epidemics with differing predominant serotypes | |
| WO2006002240A3 (en) | Computer systems and methods for constructing biological classifiers and uses thereof | |
| WO2005056839A3 (de) | Primer und sonden zum nachweis genitaler hpv-genotypen | |
| JP2020533604A5 (de) | ||
| Catania | Immunology: The science of pandemics, infectious disease and COVID-19 | |
| TWI485252B (zh) | 一種以糞便中細胞基因套組偵測大腸直腸癌可能性的方法 | |
| Salas et al. | P374 Overlap between amsel’s criteria, nugent’s gram stain score, and vaginal microbiota community state types | |
| Griffin et al. | Co-infection with hepatitis C virus increases mortality in HIV-1 infected patients through increased liver-related deaths rather than by increasing malignancy related deaths. | |
| Lawrence Kogan et al. | 08CHAPTER | |
| Xu et al. | Conjunctival polymerase chain reaction tests (RT-PCR) of COVID-19 patients in Shenyang, China | |
| WO2006099569A3 (en) | Methods and compositions for beryllium-induced disease | |
| Chavis | 10080 Quantifying type of dental treatment rendered for patients with special needs | |
| Noeldner et al. | 79. Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal PCR Assays Beyond Respiratory Infections | |
| LeGoff et al. | Respiratory Torque Teno Virus load at Emergency department visit predicts intensive care unit admission of SARS-CoV-2 infected patients | |
| Huntington et al. | What is the best approach for patients with ASCUS detected on Pap smear? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |